영문으로 운영되고 있는 삼성바이오에피스 SNS에 포스팅된 글입니다.
Driving a Biosimilar-First Strategy in US Healthcare
2026/02/10
[Re:Access Newsletter] Keeping Up With the Evolving Biosimilar Landscape
2026/01/06
Biosimilar Market Trends, Latest Updates and their Implications
2025/12/11
Samsung Bioepis 2025 Year in Review: Shaping the Next Chapter in Biosimilar...
2025/12/09
[Re:Access] Stakeholders Hold the Key to Unlocking Biosimilar Potential
2025/12/02
[Re:Access] Biosimilar Regulation is Improving, But Still Needs Work
2025/11/03